STOCK TITAN

AN2 Therapeutics: Commodore reports 9.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

AN2 Therapeutics, Inc. (ANTX) was the subject of an amended ownership report in which Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson and Michael Kramarz each reported shared beneficial ownership of 3,879,705 shares, or 9.9%, as of September 30, 2026. The reported amount comprises 2,933,680 common shares and 946,025 shares acquirable upon exercise of a pre-funded warrant.

AN2 reported 37,889,862 common shares issued and outstanding as of September 30, 2026; the ownership percentage calculation also included the 946,025 shares acquirable under the warrant.

Beneficial ownership 3,879,705 shares Shared amount reported by each filer as of September 30, 2026
Ownership percentage 9.9% Percentage of class reported by each filer
Common shares 2,933,680 shares Part of the reported beneficial ownership
Shares acquirable under pre-funded warrant 946,025 shares Included in the reported beneficial ownership
Beneficial Ownership Limitation 9.99% Limit applicable to the pre-funded warrant
Excluded warrant shares 1,334,684 shares Underlying shares excluded from the reported beneficial ownership due to the limitation
Shares issued and outstanding 37,889,862 shares As of September 30, 2026; ownership percentage calculation also included 946,025 acquirable shares
Pre-Funded Warrant financial
"right to acquire through the exercise of a Pre-Funded Warrant"
A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.
Beneficial Ownership Limitation financial
"subject to a beneficial ownership limitation of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AN2 Therapeutics shares did the reporting persons beneficially own?

The four reporting persons each reported shared beneficial ownership of 3,879,705 shares, equal to 9.9% of the class, as of September 30, 2026.

How many ANTX warrant shares were excluded from beneficial ownership?

The report excluded 1,334,684 shares underlying the pre-funded warrant because the warrant is subject to a 9.99% Beneficial Ownership Limitation.

Who has investment discretion over the reported ANTX shares?

Commodore Capital LP is the investment manager to Commodore Capital Master LP. Michael Kramarz and Robert Egen Atkinson are managing partners of Commodore Capital LP and exercise investment discretion over the securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





037326105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Commodore Capital LP
Signature:Michael Kramarz
Name/Title:Managing Partner
Date:11/16/2026
Commodore Capital Master LP
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:11/16/2026
Robert Egen Atkinson
Signature:Robert Egen Atkinson
Name/Title:Authorized Signatory
Date:11/16/2026
Michael Kramarz
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:11/16/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement

Keep reading